EP2879661
INNDÆLANLEGAR EFNASAMSETNINGAR SEM INNIHALDA LETRÓSÓL EÐA ANASTRÓSÓL
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.7.2013EP published:
26.1.2022EP application number:
13742226.7
EP translation filed:
30.3.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
28.7.2033Expiry date:
28.7.2026Next due date:
31.7.2026
Title in English:
INJECTABLE COMPOSITIONS COMPRISING LETROZOLE OR ANASTROZOLELanguage of the patent:
English
Timeline
Today
29.7.2013EP application
26.1.2022EP Publication
30.3.2022Translation submitted
15.5.2022Registration published
28.7.2026Expires
Owner
Name:
Laboratorios Farmacéuticos Rovi, S.A.Address:
C/ Julián Camarillo 35, 28037 Madrid, ES
Inventor
Name:
FRANCO RODRÍGUEZ, GuillermoAddress:
E-28037 Madrid, ES
Name:
GUTIERRO ADURIZ, IbonAddress:
E-28037 Madrid, ES
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201231271Date:
3.8.2012Country:
ES
Classification
Categories:
A61K 9/00, A61P 35/00, A61K 31/4196, A61K 9/10, A61K 47/34, A61K 47/20
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 12.7.2022
Expires: 28.7.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 13.7.2023
Expires: 28.7.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 11.7.2024
Expires: 28.7.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 13
Paid: 10.7.2025
Expires: 28.7.2026
Payer: G.H. Sigurgeirsson ehf.